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Human sex hormone-binding globulin (hSHBG) and rat androgen-binding protein (rABP) exhibit distinct afilnities for sex-steroids. We therefore 
constructed and expressed a hSHBG/rABP hybrid cDNA encoding the N-terminal portion of hSHBG (205 residues) and the C-terminal portion 
of rABP (168 residues). The resulting chimera displayed similar steroid-binding characteristics a hSHBG and was recogniscd by a monoclonal 
antibody (SlB5) for hSHBG. We then created substitutions at Ser-133, His-136 and Met-139. The Asp-133 and Gin-136 mu*zmts bound steroids 
in the same way as normal hSHBG while the steroid-binding aflinity of Trp-I 39 was reduced. All three mutants cross-reacted similarly in a hSHBG 
radioimmunoassay, but Gin-136 was recognised poorly by the Sl BS antibody. Thesedata imply that residues involved in steroid-binding are located 
within the N-terminal half of hSHBC and include Met-139, and that the SIB5 epitopc is located in this region. 
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1. INTRODUCTION 
Human sex hormone-binding lobulin (hSHBG) is a 
plasma glycoprotein that modulates the bioavailability 
of testostercme and estradiol [1,2]. The rat testis pro- 
duces a structurally related molecule [3], known as an- 
drogen-binding protein (rABP), that binds sex steroids 
with lower affinity than hSHBG [4]. Affinity-labelling 
studies of the hSHBG and rABP steroid binding sites 
have produced inconsistent results [5-lo], and it is un- 
clear whether amino acids that interact with steroid 
ligands are confined to a discrete region surrounding 
Met-139 [5-71 or are dispersed throughout he molecule 
[8-lo]. To resolve this issue, the primary structures and 
steroid-binding affinities of SHBG-related molecules in 
different species [8,1 l-l 31 were compared, and this in- 
formation was used to create a hSHBGlrhBP chimera 
and three hSHBG mutants in which amino acid substi- 
tutions were predicted to influence steroid binding. 
These recombinant proteins were expressed in Chinese 
hamst.er ovary (CHO) cells, and their steroid-binding 
characteristics and immunological properties have ena- 
bled us to identify amino acids involved in steroid bind- 
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ing and the epitope for a monoclonal antibody against 
hSHBG [ 141. 
2. MATERIALS AND METHODS 
2.1. Consrruetior~ ml expression of a ASHBGhABP citintuu und 
A cDNA for the hSHBG precursor [15] was sub-cloned into the 
NorI site 01’ a modified pBluescript vector (Stratagene, La .lolla, CA) 
that lacks an EcoRl site. This construct was digested with EcoRI to 
remove 553 base pairs ibp) from the 3’ end of the hSHBG cDNA. and 
this was replaced with the corresponding 3’rABP cDNA fragment [3]. 
The hybrid cDNA was inserted into the lVor1 site of pRc/CMV (In- 
vitrogen, San Diego, CA) for expression, as described previorrsly [l 51. 
After selection in the presence of G418. stably transfected cells were 
washed in phosphate-buffered saline to remove fetal calf serum, and 
were cultured in Dulbecco’s modified Eagle medium for 2 days. 
For site-directed mutagenesis. the hSHBG cDNA was inserted into 
a ffi/rdlIl/XbcrI-digested pSclcct-l vector (Promega Corp., Madison, 
WI), and mutated using oligonucleotide primers to convert he colons 
for Scr-l33(AGC)+Asp(GAC), His-136(CAT)-+Gln(CAA), and 
Met-l39(ATG)+Trp(TGG) using the protocol recommended by 
Promega. The mutated cDNAs were sequenced to confirm that only 
targeted mutations had occurred, and then inserted into HindlIIlXbrrI- 
digested p!?cKMV for expression i CHO cells [l5]. 
2.2. Meusuremenis of srcroid-binding characrcrisrics and iw~rwochem 
icul unalyscs 
The steroid-binding capacity of recombinant prolcins in medium 
from CHO cell cultures was determined by saturation analysis using 
[JH]5cr-dihydrotestosterone (DHT) as labelled ligand and dextran- 
coated chamal (DCC) to separate bound and free steroid [16]. The 
apparent dissociation rate of protein-bound [‘H]DHT was also as- 
sessed by exposure to DCC for increasing time at 0% 1161, and affinily 
Mnstants were measured by Scatchard analysis [16,17]. Relative bind- 
ing affinities were also determined using [‘H]DHT as‘ labelb:d &and 
and increasing amounts of DHT, testosterone. and 17&estradiol as 
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competitors [la]. The immunochemical propcrtics of recombinant 
proteins were examined using an immunoradiometric assay [181 that 
relies on a monoclonal antibody (SI B5) specific for hSHBG [ 141, and 
a radioimmunoassay to assess their ability to compete with 
[‘z’I]hSHBG for a polyclonul antiserum [ltt]. Samples of culture me- 
dium (I 5 ~1) were also subjected to polyacrylumidc gel electrophorcsis 
(PAGE) and Western analysis, as described previously [151. 
3, RESULTS AND DISCUSSION 
Human SHBG and rABP both comprise 373 amino 
acids and exhibit 68% sequence identity [3]. Their 
cDNAs contain a conserved internal EcoRI site and this 
enabled us to conveniently create a hybrid cDNA en- 
coding a hSHBG/rABP chimera (Fig. 1). Since rABP 
has a lower affinity for androgens than hSHBG [4], and 
amino acids in both halves of hSHBG have been affin- 
ity-labelled [5-IO], we predicted that analyses of this 
chimera would help determine whether the C-terminal 
region plays LI direct role in steroid binding. When ex- 
pressed in Cl10 cells, the apparent dissociation rate 
(Fig. 2A), steroid-binding affinity (Fig. 2B), and speci- 
ficity (relative binding affinity: DHT = 1.00, testoster- 
one = 0.18, estradiol = 0.05) of the chimera were similar 
to normal hSHBG [IS], and this is remarkable because 
35% of the residues in the C-terminal portion of the 
chimera are specific for rABP (Fig. 1). Thus, although 
conserved residues in the C-terminal portions of 
hSHBG and the chimera may be necessary for appro- 
priate folding and dimerization, these data suggest hat 
amino acids within the N-terminal half of hSHBG are 
responsible for its unique steroid-binding properties. 
To further investigate the N-terminal portion of 
hSHBG, its primary structure was compared with 
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Fig. I I Diagram of the hSHBG/rABP chimera nd bSHBG mutants. 
Both proteins comprise 373 amino acids. Vcrticai lines indicate posi- 
tions oF rABP-specific amino acids within the chimcrd, and the 3 
amino acids in RSHBG altered by site-directed mutsgcncsis. The con= 
served EcoRI site in the hSHBG [8] and rABP [3] cDNAs encompasses 
the codonr for Glu-205 and Ptre-206, and its relative position is shown 
as a broken vertical line. Closed boxes indicats the positions of N- 
linked oligosaccharide chains at reridues 244 and 367 in the chimera, 
and 351 and 361 in the hSHBG mutants, while the O-linked oligosac- 
chatidc at position 7 is shown as an open box. 
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Fig, 2. Measurements ofthe apparent dissociation rate measurements 
(A) and Scatchard analysis (B). After IO min exposure to dexlran- 
coated charcoal (DCC) ut O’C, the dissociation of[“H]DHT from the 
Trp. I39 mutant was 67%. but was ~5% for the remaining recombinant 
proteins (A). Dissociation constants are: 0.40 nM for normal hSHBG; 
0.34 nM for Asp-133: 0.35 nM Tar Gin-136; 0.40 nM for the hSHBG/ 
rABP chimera, and 2.08 nM for Trp.139 (B). 
SHBG-related proteins in other mammalian species 
that resemble rABP in terms of their steroid-binding 
properties [4,12,19]. This revealed a sequence of poorly 
conserved polar amino acids adjacent o a conserved 
hydrophobic region (Fig. 3). Included within this region 
is a conserved residue (Met-139) that has previously 
been affinity-labelled in hSHBG [S], and when this was 
substituted by tryptophan the resultant mutant dis- 
played a marked reduction in steroid-binding affinity, 
as assessed by both dissociation rate (Fig. 2A) and 
Scatchard analyses (Fig. 2B). Based on the phylogenetic 
131 140 149 
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Fig. 3. Phylogenetic comparison of SHBG-related protein scquenccs 
between residues 13 l-149. Amino acids identical tc hSHBG are shown 
as dashes. Amino acids within the boxed areas were targets for site- 
directed mutagenesis, 
228 
Volume 301, number 2 FEBS LETTERS April 1992 
A 12 
T 
s 10 
1 A-AGln-136 8 
Cl-IJChlmera 
t 6 
4 4 
8 N 2 
t 
0 
0.05 0.10 1.00 1050 
pmol pratoln/mL (WA) 
O-O 
a-0 
A-A 
Normal 
Asp-1 35 
Gin-1; 
Trp-‘l 39 
Chimer0 
cc: : 
1 .OD 
pm01 pratoin/mL (WA) 
Fig. 4. Analysts of normal hSHBG, the hSHDG/rABP chimera and 
hSHBG mutants by (A) immunoradiomctric assay and (B) radioim- 
munoassay. A steroid-binding capacity assay (BCA) was used to de. 
finr the amounts or protein anulysed. 
comparison of SHBG-related protein sequences within 
this region (Fig. 3), we also converted Ser-133 and His- 
136 in hSHBG, independently, toAsp-l 33 and Gin-136. 
because these residues are conserved in rat. mouse and 
rabbit ABP (Fig. 3). However, the steroid-binding affin- 
ities (Fig. 2) and specificities (data not shown) of these 
mutants were indistinguishable from those of normal 
hSHBG [15]. Two independent immunochemicai ap 
proaches were used to demonstrate that the tertiary and 
quaternary structures of the Trp-139 mutant were not 
markedly altered. In a two-site immunoradiometric 
assay based on the use of a single monocionnl antibody 
that recognises a conformational epitope on both sub- 
units of hSHBG [20], the Trp-139 and Asp- I33 mutants 
showed very similar immuno-reactivity to normal 
hSHBG, while the Gin-I 36 mutant reacted poorly with 
this antibody (Fig. 4A). However, ail three mutants 
displayed similar cross-reactivity with hSHBG in a radi- 
oimmunoassay (Fig. 4J3) that relies on the use of a 
poiycionai antiserum against hSHBG [18]. These data 
demonstrate that the decreased steroid-binding affinity 
of the Trp- 139 mutant is not due to a gross alteration 
in protein structure. It also appears that Gin-136 dis- 
rupts the Sl I35 epitope withour influencing steroid bind- 
kDa 
Fig. 5. Western blot of normal hSH5G. the hSHBG/rABP chimera 
and hSH5G mutants. Proteins were resolved by 7.5% PAGE under 
denaturing and reducing conditions, clectrophorctically transferred to 
a nylon mcmbranc, and dstcctcd immunochemically [ IS]. Conditioned 
medium from Chinese hamster ovary cells (Cl-IO-CM) represents a 
negative control, and the positions of size standards (stds) arc shown 
on the right. The positions of the heavy (H) and light (L) subunits 
typicul ot’ hSHBG arc shown on the Icfi. 
ing (Fig. 4A), or the overall conformation of the moie- 
cule as assessed by the integrity of epitopcs recognised 
by a poiyvalent antiserum (Fig. 4B). The sensitivity of 
this type of immunochemicai pproach for the detection 
of structural alterations is illustrated by the poor cross- 
reactivity of the chimera in the radioimmunoassay (Fig. 
4B), and obviously reflects a loss of epitopes within the 
C-terminal portion of the molecule. However, the chi- 
mera cross-reacts significantly with the SlB5 antibody, 
and this supports the concept hat its epitope is confined 
largely to the N-terminal portion of the molecule. 
The chimera and ail three mutants were secreted in 
approximately equal amounts, as assessed by steroid- 
binding capacity, immuno-reactivity and Western blot- 
ting (Fig. 5). The recombinant forms of SHBG migrate 
with mobiiities identical to normal hSHBG during 
PAGE under native conditions [i5], and this is indica- 
tive of dimer formation (data not shown). Furthermore, 
the hSHBC mutants displayed the typical size heterogc- 
neity associated with hSHBG subunits [IS] when sub- 
jected to PAGE under denaturing conditions (Fig. 5). 
The chimera also resolved into subunits with slightly 
lower mobiiitics than the typical heavy and light 
isoforms of the hSHBG monomers when anaiysed in 
this way (Fig. 5). This probably reflects the addition of 
more complex carbohydrate structures on both consen- 
sus sites for N-giycosylation within the chimera (Fig. 1). 
However, this does not affect steroid binding, and car- 
bohydrates attached to the non-conserved N-giycosyia- 
tion sites do not therefore appear to be involved in this 
process. 
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